Neuroblastoma

Childhood cancer survivors are more than twice as likely to develop melanoma as the general population, according to findings published in Journal of Clinical Oncology.

CHICAGO — Time between therapy regimens can safely be offered to certain children with cancer to promote quality of life and explore goals of care without negatively affecting survival, according to data presented at ASCO Annual Meeting.

Exclusive breastfeeding for at least 3 months was associated with reduced childhood hematologic cancer risk vs. shorter breastfeeding durations, according to cohort study results published in JAMA Network Open.

Individuals with tooth agenesis may be more likely to develop several different cancer types from childhood through young adulthood, according to results published in JAMA Network Open.

Determining risk classifications of children with neuroblastoma is “paramount” to optimizing their care, the chair of the first National Comprehensive Cancer Network guidelines panel on the disease, told Healio.

The FDA approved eflornithine for adults and children with high-risk neuroblastoma.

September is Childhood Cancer Awareness Month.

The first patient has been dosed in a clinical trial with electron accelerator-produced Cu-67, according to a Wisconsin-based company specializing in radiopharmaceuticals for therapeutic and medical imaging applications announced.

CHICAGO — Survivors of high-risk neuroblastoma face a substantial burden of late toxicity, according to study results presented at ASCO Annual Meeting.

Lorlatinib appeared safe and showed potential efficacy among a cohort of patients with relapsed or refractory, ALK-driven, high-risk neuroblastoma, results of a phase 1 trial showed.